B. Riley Wealth Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
B. Riley Wealth Advisors's UTHR Position: Q1 2026 in Review
B. Riley Wealth Advisors sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 653 shares — an estimated $318K sold.
B. Riley Wealth Advisors first reported a position in UTHR in Q2 2013 and held it in 16 quarters. The position peaked at $357K in Q3 2024. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- B. Riley Wealth Advisors reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- B. Riley Wealth Advisors sold 653 United Therapeutics shares in Q1 2026, an estimated $318K.
- B. Riley Wealth Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 16 quarters.
- B. Riley Wealth Advisors's United Therapeutics position peaked at $357K in Q3 2024.
- 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.